MannKind Corp.

CT drugmaker partners on development of inhaled weight-loss treatment

The partnership involving Danbury-based MannKind Corp. will test whether a fast-acting inhaled GLP-1 drug could offer patients more flexibility than existing treatments.

Get our email newsletters

Stay up-to-date on the companies, people and issues that impact businesses in Hartford and beyond.

Latest Stories

Zoning change clears path for Splash Car Wash in...

🔒 Stamford doctor, medical practices to pay $866K to...

🔒 Greater Hartford home prices climb 11% in September...

Hartford considers 15-year tax deal for $29M affordable housing...

More Business News

Thought Leadership

How the Right Banking Partner Can Free Up Time...

Expanding health coverage options for Connecticut businesses

More Thought Leadership

Movers & Shakers

Ascend Bank Welcomes JP Aldi as Vice President and Commercial Officer

HarperWhitfield, P.C. Announces Gregg Lionetti, CPA, CVA, Named Partner

Hartford Public Library Welcomes Lucy Nalpathanchil as Its New Chief Advancement Officer

Justin Jetmar, PE, MBA, PMP, Joins Weston & Sampson in their Rocky Hill Office

More Movers & Shakers | Submit Movers & Shakers

Business Announcements

U.S. Senator Visits Flow Tech to Discuss Employee Ownership

Essex Bank is celebrating its 175th anniversary

More Announcements | Submit Business Announcements

Upcoming Events

More Events | Submit an Event

Cranes & Scaffolds: 4th Annual Commercial Real Estate Conference

Connecticut’s Health Care Heroes 2026 Awards